Asymmetric Organocatalytic Aldol Reaction
FULL PAPER
A
analysis calcd(%) for C 17H23NO4 (305.4): C 66.86, H 7.59, N 4.59; found:
C 66.64, H 7.69, N 4.63.
[(2S,1’R)-3g]:[27] The enantiomeric excess was determined by HPLC
(Daicel Chiralpak AD, heptane/iPrOH 97:3, flow rate 0.5 mLminꢀ1, l=
254 nm): tR =140.1 min (minor), tR =145.9 min (major). Data for the
major isomer (2S,1’R)-3g: 1H NMR (400 MHz, CDCl3): d=1.45–1.73 (m,
3H; cyclopent-H), 1.91–2.00 (m, 1H; cyclopent-H), 2.16–2.44 [m, 3H;
CH2C(O) + CHCHOH], 4.69 (d, J=0.9 Hz, 1H; CHOH), 4.78 (d, J=
9.2 Hz, 1H; CHOH), 7.45–7.49 (m, 2H; ArH), 8.13–8.17 ppm (m, 2H;
ArH); 13C NMR (100 MHz, CDCl3): d=20.4 (CH2), 26.9 (CH2), 38.6
(CH2), 55.1 (CH), 74.4 (CH), 123.6 (CH, 2C), 127.2 (CH, 2C), 147.5 (C),
148.5 (C), 222.0 ppm (C).
(2S,4S,1’R)-4-tert-Butyl-2-[1’-hydroxy-1’-(2-nitrophenyl)methyl]cyclohex-
an-1-one [(2S,4S,1’R)-3l]: The enantiomeric excess was determined by
HPLC (Daicel Chiralpak AD, heptane/iPrOH 85:15, flow rate
0.4 mLminꢀ1, l=210 nm): tR =22.7 min (minor), tR =25.8 min (major).
Data for the major isomer (2S,4S,1’R)-3l: M.p. 83–848C; [a]2D2 =ꢀ4.5 (c=
1.00 in CHCl3, 90% ee); 1H NMR (400 MHz, CDCl3): d=0.78 (s, 9H;
CH3), 1.50–1.70 (m, 4H; cyclohex-H), 1.88–1.93 (m, 1H; cyclohex-H),
2.37–2.46 [m, 2H; CH2C(O)], 2.80–2.86 (m, 1H; CHCHOH), 3.55 (br,
1H; CHOH), 5.46 (d, J=7.2 Hz, 1H; CHOH), 7.43 (dt, J=7.8, 1.4 Hz,
1H; ArH), 7.63 (dt, J=8.4, 1.4 Hz, 1H; ArH), 7.73 (dd, J=8.0, 1.4 Hz,
1H; ArH), 7.84 ppm (dd, J=8.0, 1.3 Hz, 1H; ArH); 13C NMR (100 MHz,
CDCl3): d=24.3 (CH2), 27.0 (CH3, 3C), 27.6 (CH2), 32.8 (C), 39.7 (CH2),
42.4 (CH), 53.7 (CH), 69.7 (CH), 124.3 (CH), 128.7 (CH), 129.1 (CH),
133.3 (CH), 136.9 (C), 148.7 (C), 216.1 ppm (C); IR (KBr): n˜ =3455,
2870, 1702, 1527, 1446, 1353, 1093, 1032, 861 cmꢀ1; MS (EI): m/z (%): 306
(53) [(M+1)+], 288 (13) [(M+1)+ꢀH2O], 155 (100), 152 (86); elemental
analysis calcd(%) for C 17H23NO4 (305.4): C 66.86, H 7.59, N 4.59; found:
C 66.48, H 7.76, N 4.63.
A
[(2S,1’R)-3h]:[27] The enantiomeric excess was determined by HPLC
(Daicel Chiralpak AD, heptane/iPrOH 96:4, flow rate 1.0 mLminꢀ1, l=
254 nm): tR =43.7 min (major), tR =67.4 min (minor). Data for the major
isomer (2S,1’R)-3h: 1H NMR (300 MHz, CDCl3): d=1.50–1.55 (m, 1H;
cyclopent-H), 1.61–1.78 (m, 2H; cyclopent-H), 1.92–2.01 (m, 1H; cyclo-
pent-H), 2.16–2.47 [m, 3H; CH2C(O)
CHOH), 4.77 (d, J=9.3 Hz, 1H; CHOH), 7.47 (t, J=7.9, Hz, 1H; ArH),
7.62–7.65 (m, 1H; ArH), 8.10 (ddd, J=8.1, 2.3, 1.1 Hz, 1H; ArH), 8.17–
8.18 ppm (m, 1H; ArH); 13C NMR (75 MHz, CDCl3): d=20.3 (CH2),
26.8 (CH2), 38.6 (CH2), 55.0 (CH), 74.3 (CH), 121.5 (CH), 122.9 (CH),
129.4 (CH), 132.6 (CH), 143.6 (C), 148.3 (C), 222.3 ppm (C).
(4R)-4-Hydroxy-4-nitrophenylbutan-1-one (3i):[27] The enantiomeric
excess was determined by HPLC (Daicel Chiralpak AS, heptane/iPrOH
70:30, flow rate 0.5 mLminꢀ1, l=254 nm): tR =26.4 min (major), tR =
35.4 min (minor). 1H NMR (400 MHz, CDCl3): d=2.22 (s, 3H; CH3),
2.84–2.86 (m, 2H; CH2CHOH), 3.59 (s, 1H; CHOH), 5.26 (dd, J=8.0,
4.3 Hz, 1H; CHOH), 7.52–7.55 (m, 2H; ArH), 8.19–8.22 ppm (m, 2H;
ArH); 13C NMR (100 MHz, CDCl3): d=30.7 (CH3), 51.5 (CH2), 68.8
(CH), 123.5 (CH, 2C), 126.3 (CH, 2C), 147.0 (C), 149.9 (C), 208.2 ppm
(C).
(2S,4S,1’R)-4-tert-Butyl-2-[1’-hydroxy-1’-(4-chlorophenyl)methyl]cyclo-
hexan-1-one [(2S,4S,1’R)-3m]: The enantiomeric excess was determined
by HPLC (Daicel Chiralpak AD, heptane/iPrOH 95:5, flow rate
0.5 mLminꢀ1, l=230 nm): tR =33.3 min (minor), tR =63.8 min (major).
Data for the major isomer (2S,4S,1’R)-3m: M.p. 150–1518C; [a]2D2 =ꢀ6.3
(c=1.00 in CHCl3, 93% ee); 1H NMR (400 MHz, CDCl3): d=0.79 (s,
9H; CH3), 1.38–1.59 (m, 4H; cyclohex-H), 1.96–2.02 (m, 1H; cyclohex-
H), 2.41–2.54 [m, 2H; CH2C(O)], 2.62 (dt, J=9.6, 6.6 Hz, 1H;
CHCHOH), 3.28 (br, 1H; CHOH), 4.86 (dd, J=9.6, 2.8 Hz, 1H;
CHOH), 7.27–7.36 ppm (m, 4H; ArH); 13C NMR (100 MHz, CDCl3): d=
25.2 (CH2), 27.2 (CH3, 3C), 27.6 (CH2), 32.9 (C), 39.3 (CH2), 42.3 (CH),
55.2 (CH), 74.2 (CH), 128.2 (CH, 2C), 128.7 (CH, 2C), 133.9 (C), 139.8
(C), 215.7 ppm (C); IR (KBr): n˜ =3472, 2958, 2871, 1699, 1486, 1091,
1041, 830 cmꢀ1; MS (EI): m/z (%): 294 (1) [M +], 276 (7) [M +ꢀH2O],
154 (66), 140 (32), 139 (100), 70 (51), 57 (35); elemental analysis calcd
(%) for C17H23O2Cl (294.8): C 69.26, H 7.86; found: C 69.19, H 8.07.
(2S,4S,1’R)-4-tert-Butyl-2-[1’-hydroxy-1’-(4-nitrophenyl)methyl]cyclohex-
an-1-one [(2S,4S,1’R)-3j]: The enantiomeric excess was determined by
HPLC (Daicel Chiralcel OD-H, heptane/iPrOH 92:8, flow rate
0.5 mLminꢀ1, l=280 nm): tR =53.4 min (major), tR =66.6 min (minor).
Data for the major isomer (2S,4S,1’R)-3j, which was obtainedin enantio-
merically pure form after recrystallization: M.p. 184–1858C; [a]2D2 =ꢀ11.4
(c=1.00 in CHCl3, ꢁ99% ee); 1H NMR (400 MHz, CDCl3): d=0.79 (s,
9H; CH3), 1.34–1.68 (m, 4H; cyclohex-H), 1.94–2.00 (m, 1H; cyclohex-
H), 2.38–2.47 (m, 1H; CHHC(O)), 2.51–2.57 [m, 1H; CHHC(O)], 2.63–
2.69 (m, 1H; CHCHOH), 3.62 (br, 1H; CHCHOH), 4.97 (dd, J=9.4,
2.9 Hz, 1H; CHCHOH), 7.53–7.55 (m, 2H; ArH), 8.23–8.25 ppm (m,
2H; ArH); 13C NMR (100 MHz, CDCl3): d=24.3 (CH2), 27.0 (CH2), 27.1
(CH3, 3C), 33.0 (C), 39.4 (CH2), 42.5 (CH), 54.4 (CH), 74.0 (CH), 123.7
(CH, 2C), 127.7 (CH, 2C), 147.7 (C), 148.5 (C), 215.7 ppm (C); IR
(KBr): n˜ =3468, 2956, 1702, 1600, 1520, 1452, 1392, 1343, 1267, 1042,
856 cmꢀ1; MS (EI): m/z (%): 305 (2) [M +], 287 (13) [M +ꢀH2O], 154
(98), 151 (72), 139 (97), 70 (78), 57 (100); elemental analysis calcd(%)
for C17H23NO4 (305.4): C 66.86, H 7.59, N 4.59; found: C 67.12, H 7.33, N
4.59.
A
one [(3S,1’R)-3n]:[12b,44b] The enantiomeric excess was determined by
HPLC (Daicel Chiralcel OD-H, heptane/iPrOH 92:8, flow rate
0.5 mLminꢀ1, l=254 nm): tR =79.7 min (major), tR =127.2 min (minor).
Data for the major isomer (3S,1’R)-3n: 1H NMR (400 MHz, CDCl3): d=
2.51 [ddd, J=13.7, 4.7, 2.2 Hz, 1H; SCHHCHC(O)], 2.66 [dd, J=13.7,
11.0 Hz, 1H; SCHHCHC(O)], 2.74–2.83 (m, 2H; SCH2), 2.94–3.04 [m,
3H; CH2C(O) + CHCHOH], 3.64 (d, J=4.1 Hz, 1H; CHOH), 5.05 (dd,
J=8.2, 3.9 Hz, 1H; CHOH), 7.54 (d, J=8.8 Hz, 2H; ArH), 8.23 ppm (d,
J=8.8 Hz, 2H; ArH); 13C NMR (100 MHz, CDCl3): d=30.8 (CH2), 32.8
(CH2), 44.8 (CH2), 59.5 (CH), 73.2 (CH), 123.8 (CH, 2C), 127.8 (CH,
2C), 147.7 (C), 147.8 (C), 211.2 ppm (C).
A
one [(3S,1’R)-3o]:[44b] The enantiomeric excess was determined by HPLC
(Daicel Chiralpak AD, heptane/iPrOH 92:8, flow rate 0.7 mLminꢀ1, l=
254 nm): tR =67.9 min (major), tR =85.0 min (minor). Data for the major
isomer (3S,1’R)-3o: 1H NMR (400 MHz, CDCl3): d=2.52 [ddd, J=13.7,
4.7, 2.2 Hz, 1H; SCHHCHC(O)], 2.68 [dd, J=13.7, 11.0 Hz, 1H;
SCHHCHC(O)], 2.76–2.85 (m, 2H; SCH2), 2.95–3.07 [m, 3H; CH2C(O)
+ CHCHOH], 3.69 (d, J=4.0 Hz, 1H; CHOH), 5.04 (dd, J=8.2, 4.0 Hz,
1H; CHOH), 7.55 (t, J=7.9 Hz, 1H, ArH), 7.70 (d, J=7.7 Hz, 1H,
ArH), 8.16–8.24 ppm (m, 2H, ArH); 13C NMR (100 MHz, CDCl3): d=
30.8 (CH2), 32.8 (CH2), 44.8 (CH2), 59.4 (CH), 73.23 (CH), 122.0 (CH),
123.2 (CH), 129.6 (CH), 133.0 (CH), 142.6 (C), 148.4 (C), 211.4 ppm (C).
(2S,4S,1’R)-4-tert-Butyl-2-[1’-hydroxy-1’-(3-nitrophenyl)methyl]cyclohex-
an-1-one [(2S,4S,1’R)-3k]: The enantiomeric excess was determined by
HPLC (Daicel Chiralcel OG, heptane/iPrOH 85:15, flow rate
0.7 mLminꢀ1, l=210 nm): tR =30.0 min (minor), tR =43.3 min (major).
Data for the major isomer (2S,4S,1’R)-3k, which was obtainedin enantio-
merically pure form after recrystallization: M.p. 154–1558C; [a]2D2 =ꢀ5.3
(c=1.00 in CHCl3, ꢁ99% ee); 1H NMR (400 MHz, CDCl3): d=0.79 (s,
9H; CH3), 1.37–1.68 (m, 4H; cyclohex-H), 1.97–2.02 (m, 1H; cyclohex-
H), 2.41–2.56 [m, 2H; CH2C(O)], 2.65–2.71 (m, 1H; CHCHOH), 3.69 (d,
J=3.3 Hz, 1H; CHOH), 4.99 (dd, J=9.3, 3.3 Hz, 1H; CHOH), 7.56 (t,
J=7.8 Hz, 1H; ArH), 7.72 (d, J=7.7 Hz, 1H; ArH), 8.18–8.21 (m, 1H;
ArH), 8.24–8.26 ppm (m, 1H; ArH); 13C NMR (100 MHz, CDCl3): d=
24.6 (CH2), 27.1 (CH3, 3C), 27.3 (CH2), 32.9 (C), 39.4 (CH2), 42.4 (CH),
54.7 (CH), 74.0 (CH), 121.9 (CH), 123.1 (CH), 129.5 (CH), 132.9 (CH),
143.5 (C), 148.2 (C), 215.7 ppm (C); IR (KBr): n˜ =3328, 2962, 1702, 1526,
1444, 1345, 1218, 1060, 823 cmꢀ1; MS (EI): m/z (%): 305 (2) [M +], 287
(13) [M +ꢀH2O], 154 (99), 151 (45), 139 (100), 70 (73), 57 (67); elemental
A
one [(3S,1’R)-3p]:[44b] The enantiomeric excess was determined by HPLC
(Daicel Chiralpak AD, heptane/iPrOH 90:10, flow rate 0.5 mLminꢀ1, l=
210 nm): tR =64.6 min (minor), tR =82.9 min (major). Data for the major
isomer (3S,1’R)-3p: 1H NMR (400 MHz, CDCl3): d=2.61 [ddd, J=13.6,
4.5, 2.4 Hz, 1H; SCHHCHC(O)], 2.73–2.84 (m, 2H; SCH2), 2.88–3.02
[m, 3H; SCHHCHC(O), CH2C(O)], 3.11–3.19 (m, 1H; CHCHOH), 5.54
(d, J=6.7 Hz, 1H; CHOH), 7.45 (dt, J=7.2, 1.5 Hz, 1H; ArH), 7.66 (dt,
Chem. Eur. J. 2007, 13, 4710 – 4722
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
4719